Virtus ETF Advisers
EBS icon

Virtus ETF Advisers’s Emergent Biosolutions EBS Stock Holding History

Virtus ETF Advisers’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$252K Buy
38,196
+18,206
+91% +$120K 0.09% 257
2026
Q2 		$168K Buy
19,990
+490
+3% +$4.1K 0.06% 306
2026
Q1 		$162K Hold
19,500
– – 0.08% 277
2025
Q4 		$241K Buy
+19,500
New +$209K 0.11% 204

Other funds holding EBS

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.11B AUM 20.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Values First Advisors
Values First Advisors Gray, Tennessee $213M AUM 20.51% 1-Year Est. Return

Virtus ETF Advisers's EBS Position: Q3 2026 in Review

Virtus ETF Advisers increased its Emergent Biosolutions (EBS) stake by 91% in Q3 2026, buying an estimated $120K and bringing the position to 38,196 shares worth $252K. The position accounts for 0.09% of the portfolio, ranked #257.

Virtus ETF Advisers first reported a position in EBS in Q4 2025 and has held it in 4 quarters since. 87 funds tracked by Wall St. Rank hold EBS as of Q3 2026.

  • Virtus ETF Advisers held 38,196 shares of Emergent Biosolutions worth $252K as of Q3 2026.
  • Virtus ETF Advisers bought 18,206 Emergent Biosolutions shares in Q3 2026, an estimated $120K.
  • Emergent Biosolutions made up 0.09% of Virtus ETF Advisers's portfolio in Q3 2026, its #257 holding.
  • Virtus ETF Advisers first reported a position in Emergent Biosolutions in Q4 2025 and has held it in 4 quarters since.
  • 87 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2026.

Based on Virtus ETF Advisers's 13F filing for Q3 2026, filed 9 Nov 2026.